Jove
Visualize
Contact Us

Related Concept Videos

Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.6K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.3K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.3K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.1K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.4K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.9K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GHF-ACL: A novel contrastive learning framework with multi-order graph structures for herb-disease association prediction.

PLoS computational biology·2026
Same author

Multimodal Information-Driven Heterogeneous Graph Neural Networks for Protein-Ligand Binding Affinity Prediction.

Journal of chemical information and modeling·2026
Same author

Identification and characterization of lncRNA-stemness-immune regulatory patterns.

Briefings in bioinformatics·2026
Same author

Comparison of systolic and diastolic CT-FFR for myocardial ischemia diagnosis.

BMC medical imaging·2026
Same author

Hypoxia-Associated Alternative Polyadenylation of CARM1 and Tumor Microenvironment Alterations in Non-Small Cell Lung Cancer.

Genes·2026
Same author

Nanopipette Reference Electrodes with Facile Fabrication and Enhanced Stability.

Analytical chemistry·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 23, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K

Supervised graph co-contrastive learning for drug-target interaction prediction.

Yang Li1, Guanyu Qiao1, Xin Gao2

  • 1College of information and Computer Engineering, Northeast Forestry University, Harbin 150004, China.

Bioinformatics (Oxford, England)
|May 13, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a supervised graph co-contrastive learning model for predicting drug-target interactions (DTIs). The novel approach enhances DTI prediction accuracy, particularly in data-limited scenarios, offering a new perspective for drug discovery.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Related Experiment Videos

Last Updated: Sep 23, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Area of Science:

  • Bioinformatics
  • Computational Chemistry
  • Machine Learning

Background:

  • Drug-Target Interaction (DTI) identification is crucial for drug discovery and repositioning.
  • Experimental DTI prediction is costly and time-consuming.
  • Existing graph learning methods struggle with limited labeled data for DTI prediction.

Purpose of the Study:

  • To develop an effective DTI prediction model using limited labeled data.
  • To leverage supervised contrastive learning for improved representation learning in DTI prediction.
  • To propose a novel end-to-end supervised graph co-contrastive learning framework for DTI prediction.

Main Methods:

  • Developed an end-to-end supervised graph co-contrastive learning model (SGCL-DTI).
  • Utilized heterogeneous networks for DTI prediction.
  • Incorporated contrastive loss based on topology and semantic features with a new sample selection strategy.

Main Results:

  • SGCL-DTI significantly outperforms state-of-the-art methods on DTI prediction tasks.
  • The model demonstrates superior performance, especially in cold-start scenarios with limited data.
  • Validation on three public datasets confirms the model's effectiveness.

Conclusions:

  • The proposed SGCL-DTI model offers a robust solution for DTI prediction, even with scarce labeled data.
  • This work provides a new research direction for applying contrastive learning in DTI prediction.
  • The method shows applicability in drug discovery and identifying drug-target pairs.